USP30-IN-20
USP30-IN-20 is an orally active USP30 inhibitor (Kd = 1.61 μM, IC50 = 12.8 μM) . USP30-IN-20 induces ferroptosis by promoting ubiquitination-mediated degradation of GPX4. USP30-IN-20 inhibits the proliferation, migration, invasion, and stemness of prostate cancer cells. USP30-IN-20 induces G0/G1 cell cycle arrest and ROS levels in prostate cancer cells. USP30-IN-20 exhibits significant anti-tumor efficacy in PC3 cell subcutaneous xenografts in mice. USP30-IN-20 can be used for the study of advanced prostate cancer[1].
Product Specifications
UNSPSC
12352005
Target
Deubiquitinase; Ferroptosis; Glutathione Peroxidase; Reactive Oxygen Species (ROS)
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
ClC(C=CC=C1)=C1[Se]C2=C(C)C3=C(O2)CC(C)CC3=O
Molecular Formula
C16H15ClO2Se
Molecular Weight
353.70
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GPX4; USP30
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NAIF1, Recombinant, Human, aa1-327, His-Tag (Nuclear Apoptosis-Inducing Factor 1, bA379C10.2, C9orf90, RP11-379C10.2)
NAIF1, Recombinant, Human, aa1-327, His-Tag (Nuclear Apoptosis-Inducing Factor 1, bA379C10.2, C9orf90, RP11-379C10.2)
Lentiviral human OR4A47 shRNA (UAS) - Lentiviral human OR4A47 shRNA (UAS, RFP) (100)